M Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir disoproxil fumarate (20 February 2024) PDF
M Notes on the Design of Bioequivalence Study: Lamivudine/Tenofovir disoproxil fumarate (18 February 2024) PDF
M Notes on the Design of Bioequivalence Study: Sulfamethoxazole/Trimethoprim/Isoniazid/Pyridoxine PDF
M Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir Disoproxil Fumarate /Dolutegravir PDF
M Notes on the design of bioequivalence study: Emtricitabine/Tenofovir Disoproxil Fumarate/Efavirenz PDF